Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori.

Literature DB >> 9683304

Severe expression of corpus gastritis is characteristic in gastric cancer patients infected with Helicobacter pylori.

S Miehlke¹, A Hackelsberger, A Meining, R Hatz, N Lehn, P Malfertheiner, M Stolte, E Bayerdörffer.

Abstract

In 50 Helicobacter pylori-infected gastric carcinoma patients the corpus gastritis was significantly higher than in matched H. pylori-positive control subjects (P < 0.01). Atrophy and intestinal metaplasia (IM) occurred significantly more often in the antrum of carcinoma patients (P < 0.01). The odds ratio for gastric carcinoma was 8.85 for high-grade corpus gastritis and 8.04 when atrophy in the antrum was present.

Entities: Disease Species

Mesh：

Year: 1998 PMID： 9683304 PMCID： PMC2062894 DOI： 10.1038/bjc.1998.475

Source DB: PubMed Journal: Br J Cancer ISSN： 0007-0920 Impact factor: 7.640

25 in total

Review 1. The Sydney System: histological division.

Authors: A B Price
Journal: J Gastroenterol Hepatol Date: 1991 May-Jun Impact factor: 4.029

2. Is gastric carcinoma an infectious disease?

Authors: P Correa
Journal: N Engl J Med Date: 1991-10-17 Impact factor: 91.245

Review 3. Too many rodent carcinogens: mitogenesis increases mutagenesis.

Authors: B N Ames; L S Gold
Journal: Science Date: 1990-08-31 Impact factor: 47.728

Review 4. A human model of gastric carcinogenesis.

Authors: P Correa
Journal: Cancer Res Date: 1988-07-01 Impact factor: 12.701

5. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks.

Authors: P Correa; J Fox; E Fontham; B Ruiz; Y P Lin; D Zavala; N Taylor; D Mackinley; E de Lima; H Portilla
Journal: Cancer Date: 1990-12-15 Impact factor: 6.860

6. Difference in expression of Helicobacter pylori gastritis in antrum and body.

Authors: E Bayerdörffer; N Lehn; R Hatz; G A Mannes; H Oertel; T Sauerbruch; M Stolte
Journal: Gastroenterology Date: 1992-05 Impact factor: 22.682

7. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.

Authors: A Nomura; G N Stemmermann; P H Chyou; I Kato; G I Perez-Perez; M J Blaser
Journal: N Engl J Med Date: 1991-10-17 Impact factor: 91.245

8. Helicobacter pylori infection and the risk of gastric carcinoma.

Authors: J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal: N Engl J Med Date: 1991-10-17 Impact factor: 91.245

9. Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum.

Authors: M E Craanen; W Dekker; P Blok; J Ferwerda; G N Tytgat
Journal: Gut Date: 1992-01 Impact factor: 23.059

10. Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa.

Authors: B C MORSON
Journal: Br J Cancer Date: 1955-09 Impact factor: 7.640

27 in total

Review 1. Optimal management of biopsy-proven low-grade gastric dysplasia.

Authors: Jung-Wook Kim; Jae Young Jang
Journal: World J Gastrointest Endosc Date: 2015-04-16

2. Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study).

Authors: S Miehlke; C Kirsch; B Dragosics; M Gschwantler; G Oberhuber; D Antos; P Dite; J Läuter; J Labenz; A Leodolter; P Malfertheiner; A Neubauer; G Ehninger; M Stolte; E Bayerdörffer
Journal: World J Gastroenterol Date: 2001-04 Impact factor: 5.742

3. Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils.

Authors: Mitsushige Sugimoto; Tomoyuki Ohno; David Y Graham; Yoshio Yamaoka
Journal: J Gastroenterol Hepatol Date: 2011-11 Impact factor: 4.029

Review 4. Is intestinal metaplasia of the stomach reversible?

Authors: M M Walker
Journal: Gut Date: 2003-01 Impact factor: 23.059

Review 5. Eradication of H pylori for the prevention of gastric cancer.

Authors: Karolin Trautmann; Manfred Stolte; Stephan Miehlke
Journal: World J Gastroenterol Date: 2006-08-28 Impact factor: 5.742

Review 6. Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors: Dacie R Bridge; D Scott Merrell
Journal: Gut Microbes Date: 2013-02-04

7. An open-labeled study of rebamipide treatment in chronic gastritis patients with dyspeptic symptoms refractory to proton pump inhibitors.

Authors: Taned Chitapanarux; Ong-ard Praisontarangkul; Nirush Lertprasertsuke
Journal: Dig Dis Sci Date: 2008-05-02 Impact factor: 3.199

8. Epidemiological link between gastric disease and polymorphisms in VacA and CagA.

Authors: Sungil Jang; Kathleen R Jones; Cara H Olsen; Young Min Joo; Yun-Jung Yoo; In-Sik Chung; Jeong-Heon Cha; D Scott Merrell
Journal: J Clin Microbiol Date: 2009-12-02 Impact factor: 5.948

9. Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Authors: Trevelyan R Menheniott; Louise O'Connor; Yok Teng Chionh; Jan Däbritz; Michelle Scurr; Benjamin N Rollo; Garrett Z Ng; Shelley Jacobs; Angelique Catubig; Bayzar Kurklu; Stephen Mercer; Toshinari Minamoto; David E Ong; Richard L Ferrero; James G Fox; Timothy C Wang; Philip Sutton; Louise M Judd; Andrew S Giraud
Journal: J Clin Invest Date: 2016-03-14 Impact factor: 14.808

10. Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils.

Authors: Mitsushige Sugimoto; Tomoyuki Ohno; David Y Graham; Yoshio Yamaoka
Journal: Cancer Sci Date: 2009-07-21 Impact factor: 6.716